Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Surgery"
DOI: 10.3389/fsurg.2023.1001741
Abstract: Introduction Diffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative… read more here.
Keywords: resection; large national; dlgg; biopsy ... See more keywords